Richard P Batycky

This inventor holds 25 USPTO granted patents and 14 published patent applications, plus 9 CIPO patents and 8 EPO patents, primarily in Pulmonary Drug Delivery. Top assignees: Civitas Therapeutics, Inc., Advanced Inhalation Research, Inc., Alkermes, Inc.. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard P Batycky. Retrieved from https://idiyas.com/inventor/richard-p-batycky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 14)

% Patents Active = 80.0

CIPO Patents = 9

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 3.5

ph-index = 14

Forward Citations = 504(Granted Patents)

Location History:

Auburndale, MA (US) (2003 - 2007)
Newton, MA (US) (2005 - 2017)

Company Filing History:

12 out of 30

Civitas Therapeutics, Inc.

patents

9 out of 22

Advanced Inhalation Research, Inc.

The Penn State Research Foundation

patents

5. 1 out of 7

Merz Pharmaceuticals Gmbh

patents

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

Areas of Expertise:

Pulmonary Delivery

Levodopa Formulations

Inhalable Epinephrine

Porous Particles

Aerosol Therapy

Therapeutic Mass

Spray-Drying

Amino Acids

Particle Composition

Motor Fluctuations

Process Humidity

Inter-Patient Variability

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12458615 - Methods for providing rapid relief of motor fluctuations in a Parkinson's disease patient (2025-11-04),

2. 9539211 - Ultra low density pulmonary powders (2017-01-10),

3. 9393210 - Capsules containing high doses of levodopa for pulmonary use (2016-07-19),

4. 9333174 - Use of simple amino acids to form porous particles (2016-05-10),

5. 9295661 - Methods for reducing inter-patient variability of levodopa plasma concentrations (2016-03-29),

6. 8945612 - Capsules containing high doses of levodopa for pulmonary use (2015-02-03),

7. 8747813 - Inhalable epinephrine (2014-06-10),

8. 8685442 - Capsules containing high doses of levodopa for pulmonary use (2014-04-01),

9. 8628754 - Highly efficient delivery of a large therapeutic mass aerosol (2014-01-14),

10. 8545878 - Capsules containing high doses of levodopa for pulmonary use (2013-10-01),

11. 8415397 - Inhalable epinephrine (2013-04-09),

12. 8268358 - Use of simple amino acids to form porous particles (2012-09-18),

13. 7947742 - Inhalable epinephrine (2011-05-24),

14. 7807200 - Formulations for spray-drying large porous particles (2010-10-05),

15. 7556798 - Highly efficient delivery of a large therapeutic mass aerosol (2009-07-07),

Hello!

Title: Richard P Batycky: A Visionary Inventor Shaping the Future of Technology

Introduction:

Richard P Batycky is a visionary inventor known for his passion for innovation and relentless pursuit of excellence in the field of technology. With a solid reputation as a trailblazer, he has inspired the next generation of innovators with his groundbreaking work. Let's delve deeper into his remarkable journey.

Latest Patents:

Richard P Batycky has an impressive record of 24 patents to his name, showcasing his commitment to pushing the boundaries of innovation. Among his latest patents are:

1. Ultra low density pulmonary powders: This invention revolutionizes pharmaceutical compositions for pulmonary delivery, offering particles with specific geometric and density characteristics to enhance drug delivery to the respiratory tract.

2. Capsules containing high doses of levodopa for pulmonary use: Another groundbreaking invention, this capsule delivers an inhalable powder composition with high levodopa content, DPPC, and specific salts, optimizing drug efficacy for patients.

Career Highlights:

Richard P Batycky has made significant contributions to the field of technology through his work at companies such as Civitas Therapeutics, Inc., and Advanced Inhalation Research, Inc. His innovative approach and tireless dedication have led to the development of cutting-edge solutions that have the potential to transform healthcare and pharmaceutical industries.

Collaborations:

Throughout his illustrious career, Richard P Batycky has collaborated with industry experts and visionaries. Some of his noteworthy coworkers include Michael M Lipp and Lloyd Johnston, who have contributed to the success of his projects and shared his commitment to innovation.

Conclusion:

In conclusion, Richard P Batycky's impact on the world of technology and innovation is undeniable. His visionary inventions and dedication to excellence have paved the way for a future where healthcare and pharmaceutical advancements continue to push boundaries and improve patient outcomes. Richard P Batycky stands as a beacon of inspiration for aspiring innovators, leaving an indelible mark on the landscape of invention.

Profile summary based on public USPTO records.